BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 2834412)

  • 1. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides.
    Margioris AN; Grino M; Protos P; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1988 May; 66(5):922-6. PubMed ID: 2834412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
    Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone and proopiomelanocortin-derived peptides are present in human myometrium.
    Clifton VL; Telfer JF; Thompson AJ; Cameron IT; Teoh TG; Lye SJ; Challis JR
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3716-21. PubMed ID: 9768689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRH-deficient mice.
    Fukuda Y; Kageyama K; Nigawara T; Kasagi Y; Suda T
    Neurosci Lett; 2004 Sep; 367(2):201-4. PubMed ID: 15331153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of melanotroph- and corticotroph-type proopiomelanocortin derivatives into blood after administration of corticotropin-releasing hormone in patients with septic shock without adrenocortical insufficiency.
    Matejec R; Löcke G; Mühling J; Harbach HW; Langefeld TW; Bödeker RH; Hempelmann G
    Shock; 2009 Jun; 31(6):553-60. PubMed ID: 18827746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and secretion of proopiomelanocortin peptides from isolated perifused dog pituitary pars intermedia cells.
    Kemppainen RJ; Zerbe CA; Sartin JL
    Endocrinology; 1989 May; 124(5):2208-17. PubMed ID: 2539971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS; Lu CL; Seidah NG; Chretien M
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing hormone and dexamethasone do not alter secretion of immunoreactive beta-endorphin from dissociated fetal hypothalamic cell cultures.
    Kapcala LP; Juang HH; Weng CF
    Brain Res; 1990 Nov; 532(1-2):76-81. PubMed ID: 2282534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide, cyclic GMP analogues and modulation of guanylyl cyclase do not alter stimulated POMC peptide release from perifused rat or sheep corticotrophs.
    Bowman ME; Robinson PJ; Smith R
    J Neuroendocrinol; 1997 Dec; 9(12):929-36. PubMed ID: 9468018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of three proopiomelanocortin subtype genes and mass spectrometric identification of POMC-derived peptides in pars distalis and pars intermedia of barfin flounder pituitary.
    Takahashi A; Amano M; Amiya N; Yamanome T; Yamamori K; Kawauchi H
    Gen Comp Endocrinol; 2006 Feb; 145(3):280-6. PubMed ID: 16242690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. II. Evidence for in vivo ultradian hypersecretion of proopiomelanocortin peptides by the isolated anterior and intermediate pituitary.
    Engler D; Pham T; Liu JP; Fullerton MJ; Clarke IJ; Funder JW
    Endocrinology; 1990 Oct; 127(4):1956-66. PubMed ID: 1976094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro.
    Roe CM; Leitch IM; Boura AL; Smith R
    J Clin Endocrinol Metab; 1996 Feb; 81(2):763-9. PubMed ID: 8636301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man.
    Jackson RV; DeCherney GS; DeBold CR; Sheldon WR; Alexander AN; Rivier J; Vale W; Orth DN
    J Clin Endocrinol Metab; 1984 Apr; 58(4):740-3. PubMed ID: 6321535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3',5'-cyclic adenosine monophosphate, and glucocorticoids.
    Gagner JP; Drouin J
    Mol Endocrinol; 1987 Oct; 1(10):677-82. PubMed ID: 2856398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an ultradian secretion of adrenocorticotropin, beta-endorphin and alpha-melanocyte-stimulating hormone by the ovine anterior and intermediate pituitary.
    Engler D; Pham T; Fullerton MJ; Clarke IJ; Funder JW
    Neuroendocrinology; 1989 Apr; 49(4):349-60. PubMed ID: 2541359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of pro-opiomelanocortin peptides and corticotropin-releasing factor in human placenta.
    Ng ML; Healy DL; Rajna A; Fullerton M; O'Grady C; Funder JW
    Malays J Pathol; 1996 Jun; 18(1):59-63. PubMed ID: 10879226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that corticotropin-releasing hormone acts as a growth hormone-releasing factor in a primitive teleost, the European eel (Anguilla anguilla).
    Rousseau K; Le Belle N; Marchelidon J; Dufour S
    J Neuroendocrinol; 1999 May; 11(5):385-92. PubMed ID: 10320566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary and interrenal function in gilthead sea bream (Sparus aurata L., Teleostei) after handling and confinement stress.
    Rotllant J; Balm PH; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2001 Mar; 121(3):333-42. PubMed ID: 11254375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.
    Chan JS; Gaspar L; Iguchi H; Seidah NG; Ling N; Chrétien M
    Clin Invest Med; 1984; 7(4):205-8. PubMed ID: 6335868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.